SMTI Stock Analysis: Buy, Sell, or Hold?
SMTI - Sanara MedTech Inc. Common Stock
$21.06
-0.58 (-2.68%)
▼
5d:
+14.46%
30d:
+6.47%
90d:
+11.37%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When SMTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called SMTI this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SMTI shows positive signals but monitor for confirmation. Market pricing in 8.5% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: SMTI shows positive signals but monitor for confirmation. Market pricing in 8.5% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.83
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.42
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SMTI is currently trading at $21.06, which is considered extended relative to its 30-day fair value range of $18.08 to $20.51. From a valuation perspective, the stock is trading at a premium (Forward PE: 41.3) compared to its historical average (32.4). At these levels, the market is pricing in 8.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SMTI is in a strong downtrend. Immediate support is located at $17.77, while resistance sits at $24.33.
Market Sentiment: SMTI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.00 (+61.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SMTI is in a strong downtrend. Immediate support is located at $17.77, while resistance sits at $24.33.
Market Sentiment: SMTI has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $34.00 (+61.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.08 -
$20.51
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.0%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 61.4% below Wall St target ($34.00)
- NEUTRAL: Trading at premium valuation - market expects 8.5% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$18.08 -
$20.51
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$17.77
Resistance Level
$24.33
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
41.29
Wall Street Target
$34.00
(+61.4%)
Revenue Growth (YoY)
18.6%
Profit Margin
-31.2%
Valuation Premium vs History
+8.5% premium
PE vs Historical
41.3 vs 32.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+8.5%
(market-implied from PE analysis)
1-Year Target
$22.85
(+9%)
2-Year Target
$24.79
(+18%)
3-Year Target
$26.90
(+28%)
3-Yr Target (if PE normalizes)
(PE: 41→32)
PE COMPRESSION
$21.11
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 41.3, Growth: 628.6%)
$71.08
(+238%)
Base:
(SPY PE: 22.1, Growth: 628.6%)
$37.99
(+80%)
Bear:
(PE: 18.8, Growth: 628.6%)
$32.29
(+53%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (115x PE), but valuation improves significantly next year (41x PE) as earnings recover.
Forward PE: 114.94 | Forward EPS (Implied): $0.18
Bull Case
$25.43
(+21%)
Analyst growth 15.0%, PE expands to 120.7
Base Case
$21.06
(0%)
Market implied 0.0%, PE stable at 114.9
Bear Case
$16.11
(-24%)
Severe decline -15.0%, PE contracts to 103.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 18, 2026 4:15 AM ET
Data refreshes hourly during market hours. Next update: 5:15 AM
Data refreshes hourly during market hours. Next update: 5:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SMTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$577 | 58 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 53 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$271 | 59 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$179 | 49 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$91 | 64 BUY |
